gliclazide has been researched along with Coronary Disease in 2 studies
Gliclazide: An oral sulfonylurea hypoglycemic agent which stimulates insulin secretion.
Coronary Disease: An imbalance between myocardial functional requirements and the capacity of the CORONARY VESSELS to supply sufficient blood flow. It is a form of MYOCARDIAL ISCHEMIA (insufficient blood supply to the heart muscle) caused by a decreased capacity of the coronary vessels.
| Excerpt | Relevance | Reference |
|---|---|---|
| "In patients with type 2 diabetes, moderate alcohol use, particularly wine consumption, is associated with reduced risks of cardiovascular events and all-cause mortality." | 2.79 | The relationship between alcohol consumption and vascular complications and mortality in individuals with type 2 diabetes. ( Blomster, JI; Chalmers, J; Chow, CK; Harrap, S; Hillis, GS; Li, Q; Mancia, G; Neal, B; Patel, A; Poulter, N; Williams, B; Woodward, M; Zoungas, S, 2014) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Blomster, JI | 1 |
| Zoungas, S | 1 |
| Chalmers, J | 1 |
| Li, Q | 1 |
| Chow, CK | 1 |
| Woodward, M | 1 |
| Mancia, G | 1 |
| Poulter, N | 1 |
| Williams, B | 1 |
| Harrap, S | 1 |
| Neal, B | 1 |
| Patel, A | 1 |
| Hillis, GS | 1 |
| Hartsleben, ChH | 1 |
| Battegay, E | 1 |
1 trial available for gliclazide and Coronary Disease
| Article | Year |
|---|---|
The relationship between alcohol consumption and vascular complications and mortality in individuals with type 2 diabetes.
Topics: Aged; Alcohol Drinking; Antihypertensive Agents; Coronary Disease; Diabetes Mellitus, Type 2; Diabet | 2014 |
1 other study available for gliclazide and Coronary Disease
| Article | Year |
|---|---|
[54-year-old patient with type 2 diabetes mellitus and increased blood pressure values].
Topics: Antihypertensive Agents; Blood Pressure Determination; Combined Modality Therapy; Coronary Disease; | 2005 |